(Q40970988)

25 September 2017

title

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. (English)

1 reference

25 September 2017

Chen G

1

1 reference

25 September 2017

Huang LD

series ordinal

2

1 reference

25 September 2017

Jiang YM

series ordinal

3

1 reference

25 September 2017

Manji HK

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

Journal of Neurochemistry

25 September 2017

published in

1 reference

25 September 2017

volume

72

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

1327-1330

1 reference

Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Increase in AP-1 transcription factor DNA binding activity by valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Mood Stabilizer Combinations: A Review of Safety and Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Chronic administration of lithium or other antidepressants increases levels of DARPP-32 in rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Activation of the Wnt signaling pathway: a molecular mechanism for lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Initiation and adaptation: a paradigm for understanding psychotropic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta -catenin and promotes GSK-3beta -dependent phosphorylation of beta -catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

A bimodal model of the mechanism of action of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Lithium and brain signal transduction systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Establishment of the dorso-ventral axis in Xenopus embryos is presaged by early asymmetries in beta-catenin that are modulated by the Wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Signal transduction pathways. Molecular targets for lithium's actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

Lithium stimulates gene expression through the AP-1 transcription factor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2000.0721327.X

10.1046/J.1471-4159.2000.0721327.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference